Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neuromuscular Blockade: later-stage trial registry
2 of 7 indexed Neuromuscular Blockade trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Neuromuscular Blockade: 7 US clinical trials tracked, 2 recruiting.
Neuromuscular Blockade is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Loma Linda University, running 1 of these trials.
Enrollment posture brief
Registry condition neuromuscular-blockade
OPEN 2 | RECR 29% | LATE 3 | EARLY 0 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)
Neuromuscular Blockade lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neuromuscular Blockade on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neuromuscular Blockade is recruiting below its size-band peers.
2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Neuromuscular Blockade trials is spread across many organizations.
Loma Linda University accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Neuromuscular Blockade enrolment sits around 154 participants.
Median target enrolment is 154 among the 7 trials that report a genuine target (sentinel values excluded). 2 of those (28.6%) plan for fewer than 100 participants.
-
Neuromuscular Blockade splits between interventional and observational designs.
3 interventional and 4 observational studies make up this index (42.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
The University of Texas Medical Branch, Galveston
NCT07203287
Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison
Loma Linda University
NCT06553131
NMBA Reversal and Postoperative Urinary Retention
Beth Israel Deaconess Medical Center
NCT06948409
The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications
Oregon Health and Science University
NCT02861131
Understanding the Cognition and Decision Making of Community Anesthesiologists
Vanderbilt University Medical Center
NCT04195178
Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
Mayo Clinic
NCT05120999
Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular
The Cleveland Clinic
NCT03322657
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Neuromuscular Blockade records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neuromuscular Blockade trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neuromuscular Blockade page
7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Neuromuscular Blockade trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Loma Linda University sponsors the most Neuromuscular Blockade trials on record, review their full trial history before evaluating a specific study. See Loma Linda University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neuromuscular Blockade condition card totals 7 registered trials; most-linked intervention Neostigmine; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.